Regeneron Pharmaceuticals, Inc. (REGN): A Bull Case Theory

We came across a bullish thesis on Regeneron Pharmaceuticals, Inc. (REGN) on Notes From The Beauty Contest’s Substack. In this article, we will summarize the bulls’ thesis on REGN. Regeneron Pharmaceuticals, Inc. (REGN)’s share was trading at $605.39 as of 29th May. REGN’s trailing and forward P/E were 15.39 and 17.39 respectively according to Yahoo Finance.

10 Best Biotech Stocks To Buy Under $20

A scientist in a lab conducting research on cell-based therapeutics and biotechnology.

Regeneron’s latest earnings report was...